Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

FOXK2 Transcription Factor and Its Emerging Roles in Cancer.

Nestal de Moraes G, Carneiro LDT, Maia RC, Lam EW, Sharrocks AD.

Cancers (Basel). 2019 Mar 20;11(3). pii: E393. doi: 10.3390/cancers11030393. Review.

2.

IKZF1 deletion and co-occurrence with other aberrations in a child with chronic myeloid leukemia progressing to acute lymphoblastic leukemia.

Klumb CE, Barbosa TDC, Nestal de Moraes G, Schramm MT, Emerenciano M, Maia RC.

Pediatr Blood Cancer. 2019 Apr;66(4):e27570. doi: 10.1002/pbc.27570. Epub 2018 Dec 4.

PMID:
30511400
3.

p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.

Faccion RS, Bernardo PS, de Lopes GPF, Bastos LS, Teixeira CL, de Oliveira JA, Fernandes PV, Dubois LG, Chimelli L, Maia RC.

Cell Oncol (Dordr). 2018 Apr;41(2):141-157. doi: 10.1007/s13402-017-0361-5. Epub 2018 Jan 26.

PMID:
29374392
4.

DNA microarray expression profiling of a new t(8;13) AML case allows identification of possible leukemogenic transformation markers.

Pozzo AR, Faria FCC, Carvalho LO, Pinho MB, Maia RC.

Rev Bras Hematol Hemoter. 2017 Oct - Dec;39(4):368-371. doi: 10.1016/j.bjhh.2017.06.003. Epub 2017 Jul 22. No abstract available.

5.

Low ABCB1 and high OCT1 levels play a favorable role in the molecular response to imatinib in CML patients in the community clinical practice.

da Cunha Vasconcelos F, Mauricio Scheiner MA, Moellman-Coelho A, Mencalha AL, Renault IZ, Rumjanek VM, Maia RC.

Leuk Res. 2016 Dec;51:3-10. doi: 10.1016/j.leukres.2016.10.005. Epub 2016 Oct 12.

PMID:
27770655
6.

11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.

Lemos LG, Nestal de Moraes G, Delbue D, Vasconcelos Fda C, Bernardo PS, Lam EW, Buarque CD, Costa PR, Maia RC.

J Cancer Res Clin Oncol. 2016 Oct;142(10):2119-30. doi: 10.1007/s00432-016-2212-6. Epub 2016 Aug 12.

7.

An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation.

Maia RC, Bonamino MH, Robaina MC, Amaral N, Bonecker S, Zalcberg IR, Klumb CE.

Blood Cells Mol Dis. 2015 Dec;55(4):347-50. doi: 10.1016/j.bcmd.2015.07.013. Epub 2015 Jul 21.

PMID:
26460258
8.

Membrane microparticles: shedding new light into cancer cell communication.

de Souza PS, Faccion RS, Bernardo PS, Maia RC.

J Cancer Res Clin Oncol. 2016 Jul;142(7):1395-406. doi: 10.1007/s00432-015-2029-8. Epub 2015 Aug 19. Review.

PMID:
26285684
9.

The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.

Nestal de Moraes G, Castro CP, Salustiano EJ, Dumas ML, Costas F, Lam EW, Costa PR, Maia RC.

Int J Oncol. 2014 Nov;45(5):1949-58. doi: 10.3892/ijo.2014.2615. Epub 2014 Aug 21.

PMID:
25174716
10.

Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre.

Maia RC, de Rezende LM, Robaina M, Apa A, Klumb CE.

Hematology. 2015 Mar;20(2):83-92. doi: 10.1179/1607845414Y.0000000173. Epub 2014 May 29.

PMID:
24875166
11.

Phosphorylated Crkl reduction levels are associated with the lowest P-glycoprotein activity levels in cells from chronic myeloid leukemia patients.

Vasconcelos FC, Nestal de Moraes G, Moellmann-Coelho A, Maia RC.

Leuk Res. 2013 Dec;37(12):1711-8. doi: 10.1016/j.leukres.2013.09.021. Epub 2013 Sep 29.

PMID:
24210993
12.

XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells.

Silva KL, de Souza PS, Nestal de Moraes G, Moellmann-Coelho A, Vasconcelos Fda C, Maia RC.

Leuk Res. 2013 Oct;37(10):1350-8. doi: 10.1016/j.leukres.2013.06.014. Epub 2013 Jul 25.

13.

The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia.

Nestal de Moraes G, Souza PS, Costas FC, Vasconcelos FC, Reis FR, Maia RC.

Leuk Res Treatment. 2012;2012:671702. doi: 10.1155/2012/671702. Epub 2012 Apr 24.

14.

Imatinib increases apoptosis index through modulation of survivin subcellular localization in the blast phase of CML cells.

Bernardo PS, Reis FR, Maia RC.

Leuk Res. 2012 Dec;36(12):1510-6. doi: 10.1016/j.leukres.2012.08.014. Epub 2012 Sep 10.

15.

Centroblastic diffuse large B cell lymphoma displays distinct expression pattern and prognostic role of apoptosis resistance related proteins.

Faccion RS, Rezende LM, Romano Sde O, Bigni Rde S, Mendes GL, Maia RC.

Cancer Invest. 2012 Jun;30(5):404-14. doi: 10.3109/07357907.2012.672844.

PMID:
22571341
16.

ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients.

Scheiner MA, da Cunha Vasconcelos F, da Matta RR, Dal Bello Figueira R Jr, Maia RC.

J Cancer Res Clin Oncol. 2012 Jun;138(6):959-69. doi: 10.1007/s00432-012-1170-x. Epub 2012 Feb 23.

PMID:
22358301
17.

Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.

de Souza PS, da Cunha Vasconcelos F, Silva LF, Maia RC.

Tumour Biol. 2012 Aug;33(4):943-56. Epub 2012 Jan 31.

PMID:
22290425
18.

P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells.

Souza PS, Vasconcelos FC, De Souza Reis FR, Nestal De Moraes G, Maia RC.

Int J Oncol. 2011 Oct;39(4):925-33. doi: 10.3892/ijo.2011.1103. Epub 2011 Jun 28.

PMID:
21720708
19.

Lack of prognostic significance of survivin in pediatric medulloblastoma.

Faccion RS, Ferreira RM, Grabois MF, Fonseca TC, de Oliveira JA, Maia RC.

Pathol Oncol Res. 2011 Dec;17(4):899-908. doi: 10.1007/s12253-011-9401-z. Epub 2011 Jun 17.

PMID:
21681603
20.

Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients.

Vasconcelos FC, Silva KL, Souza PS, Silva LF, Moellmann-Coelho A, Klumb CE, Maia RC.

Cytometry B Clin Cytom. 2011 May;80(3):158-66. doi: 10.1002/cyto.b.20580. Epub 2010 Dec 2.

Supplemental Content

Loading ...
Support Center